No link between omega-3s & metabolic syndrome: Study
Increased dietary intakes of omega-3 fatty acids are not linked to a reduction in the risk of metabolic syndrome in the US population, suggests a new study.
Increased dietary intakes of omega-3 fatty acids are not linked to a reduction in the risk of metabolic syndrome in the US population, suggests a new study.
A new warning letter illustrates FDA’s stance on the obligations of private label distributors to ‘ensure that all phases of the production of [a] product are in compliance with dietary supplement CGMP requirements’.
Concerns about chondroitin sources and adulteration are being tackled head on by Synutra Ingredients, which is offering ‘adulterant-free branded chondroitin products with guaranteed source traceability’, said the company’s president.
The Vermont House of Representatives has passed H.112, a bill requiring the labeling of all genetically engineered (GE) food sold in Vermont. However, there are plenty of hurdles ahead.